Trials / Completed
CompletedNCT01830153
RAD001 in Advanced Sarcoma
A Phase II Multicenter Trial of RAD001 in Patients With Metastatic or Recurrent Sarcomas
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
This trial intends to test the efficacy and safety of RAD001 in patients with advanced sarcoma who failed to conventional chemotherapy.
Detailed description
This multicenter, phase II trial evaluated the efficacy and safety of everolimus in patients with metastatic or recurrent bone and soft tissue sarcoma after failure of anthracycline and/or ifosfamide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RAD001 |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2013-01-01
- First posted
- 2013-04-12
- Last updated
- 2013-04-12
Locations
8 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01830153. Inclusion in this directory is not an endorsement.